Aug 12 |
Buy Russell 1000 Health Care Growth, says Oppenheimer in highlighting top sector ideas
|
Aug 8 |
Statutory Profit Doesn't Reflect How Good Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are
|
Aug 7 |
Neurocrine Biosciences to Present at the Canaccord Genuity 44th Annual Growth Conference
|
Aug 6 |
Is Neurocrine (NBIX) a Solid Growth Stock? 3 Reasons to Think "Yes"
|
Aug 2 |
Neurocrine Biosciences Delivering Strong Core Results, And Significant Pipeline Value Could Be On The Way
|
Aug 2 |
Vir retreats from infectious disease; Vertex shelves AATD drugs
|
Aug 1 |
Neurocrine Biosciences, Inc. (NBIX) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Compared to Estimates, Neurocrine (NBIX) Q2 Earnings: A Look at Key Metrics
|
Aug 1 |
Neurocrine Biosciences (NBIX) Lags Q2 Earnings Estimates
|
Aug 1 |
Neurocrine: Q2 Earnings Snapshot
|